UNH

Prezzo UnitedHealth Group

Closed
UNH
$368,78
-$1,70(-0,45%)

*Data last updated: 2026-05-04 07:21 (UTC+8)

As of 2026-05-04 07:21, UnitedHealth Group (UNH) is priced at $368,78, with a total market cap of $334,73B, a P/E ratio of 24,91, and a dividend yield of 2,39%. Today, the stock price fluctuated between $367,09 and $372,89. The current price is 0,46% above the day's low and 1,10% below the day's high, with a trading volume of 4,68M. Over the past 52 weeks, UNH has traded between $234,60 to $381,00, and the current price is -3,20% away from the 52-week high.

UNH Key Stats

Yesterday's Close$370,48
Market Cap$334,73B
Volume4,68M
P/E Ratio24,91
Dividend Yield (TTM)2,39%
Dividend Amount$2,21
Diluted EPS (TTM)13,23
Net Income (FY)$12,05B
Revenue (FY)$447,56B
Earnings Date2026-08-04
EPS Estimate4,83
Revenue Estimate$110,73B
Shares Outstanding903,51M
Beta (1Y)0.408
Ex-Dividend Date2026-03-09
Dividend Payment Date2026-03-17

About UNH

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
SectorHealthcare
IndustryMedical - Healthcare Plans
CEOStephen J. Hemsley
HeadquartersEden Prairie,MN,US
Employees (FY)390,00K
Average Revenue (1Y)$1,14M
Net Income per Employee$30,91K

UnitedHealth Group (UNH) FAQ

What's the stock price of UnitedHealth Group (UNH) today?

x
UnitedHealth Group (UNH) is currently trading at $368,78, with a 24h change of -0,45%. The 52-week trading range is $234,60–$381,00.

What are the 52-week high and low prices for UnitedHealth Group (UNH)?

x

What is the price-to-earnings (P/E) ratio of UnitedHealth Group (UNH)? What does it indicate?

x

What is the market cap of UnitedHealth Group (UNH)?

x

What is the most recent quarterly earnings per share (EPS) for UnitedHealth Group (UNH)?

x

Should you buy or sell UnitedHealth Group (UNH) now?

x

What factors can affect the stock price of UnitedHealth Group (UNH)?

x

How to buy UnitedHealth Group (UNH) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Hot Posts su UnitedHealth Group (UNH)

SelfRugger

SelfRugger

05-02 04:42
UnitedHealth Faces Probes And CEO Shift As Valuation Gap Widens =============================================================== Simply Wall St Thu, February 19, 2026 at 2:11 PM GMT+9 3 min read In this article: UNH -0.31% Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. * UnitedHealth Group (NYSE:UNH) is working through a difficult period marked by CEO turnover, federal probes into its Medicare billing practices, and fresh regulatory proposals affecting Medicare Advantage. * To stabilize operations and address government concerns, the company has reinstated its longtime CEO and initiated independent reviews of internal processes. * A proposed flat Medicare Advantage payment rate is drawing attention because of its potential to affect future profitability and plan economics. For investors tracking NYSE:UNH, the recent stream of operational and regulatory challenges comes alongside a share price of $288.2 and a 1 year return of a 42.2% decline. Over the past month the stock shows a 12.9% decline, while the year to date return is a 14.3% decline. This highlights how sentiment has reset as these issues have unfolded. Looking ahead, many investors are likely to focus on how quickly management can complete its reviews, respond to regulators, and address questions around Medicare billing and oversight. The outcome of the Medicare Advantage payment proposal, along with any follow up rulemaking, could be important in shaping how the business approaches growth, capital allocation, and risk management. Stay updated on the most important news stories for UnitedHealth Group by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on UnitedHealth Group. NYSE:UNH 1-Year Stock Price Chart Does the team leading UnitedHealth Group have what it takes? See our full breakdown of the management team's track record and compensation. ### Quick Assessment * **✅ Price vs Analyst Target**: At US$288.20 versus a consensus target of US$364.63, the price sits about 21% below where analysts, on average, think it could trade. * **✅ Simply Wall St Valuation**: Simply Wall St estimates the shares are trading 64.8% below fair value, which is a large valuation gap. * **❌ Recent Momentum**: The 30 day return of a 12.9% decline shows sentiment has been weak as regulatory and leadership issues play out. There is only one way to know the right time to buy, sell or hold UnitedHealth Group: head to Simply Wall St's company report for the latest analysis of UnitedHealth Group's Fair Value. ### Key Considerations * 📊 This news focuses attention on how regulatory probes, Medicare billing scrutiny, and leadership changes could affect the long term earnings profile that underpins any valuation gap. * 📊 Keep an eye on outcomes of the independent process reviews, any commentary from regulators, and updates on the proposed flat Medicare Advantage payment rates. * ⚠️ The highlighted minor risk is the company's high level of debt, which could matter more if regulatory actions increase costs or constrain profitability. Story Continues ### Dig Deeper For the full picture including more risks and rewards, check out the complete UnitedHealth Group analysis. Alternatively, you can visit the community page for UnitedHealth Group to see how other investors believe this latest news will impact the company's narrative. _ This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ _Companies discussed in this article include UNH._ **Have feedback on this article? Concerned about the content? Get in touch with us directly.**_ Alternatively, email [email protected]_ Terms and Privacy Policy Privacy Dashboard More Info
0
0
0
0